About [4-[3-[1-(3-methoxypropyl)benzimidazol-2-yl]piperidin-1-yl]-4-oxo-1-[4-(4-phenylpiperazin-1-yl)phenyl]butan-2-yl]carbamic acid
[4-[3-[1-(3-methoxypropyl)benzimidazol-2-yl]piperidin-1-yl]-4-oxo-1-[4-(4-phenylpiperazin-1-yl)phenyl]butan-2-yl]carbamic acid (PubChem CID 66786181) has the molecular formula C37H46N6O4
and a molecular weight of 638.81 g/mol. Its IUPAC name is [4-[3-[1-(3-methoxypropyl)benzimidazol-2-yl]piperidin-1-yl]-4-oxo-1-[4-(4-phenylpiperazin-1-yl)phenyl]butan-2-yl]carbamic acid.
Molecular Properties
| Compound Name | [4-[3-[1-(3-methoxypropyl)benzimidazol-2-yl]piperidin-1-yl]-4-oxo-1-[4-(4-phenylpiperazin-1-yl)phenyl]butan-2-yl]carbamic acid |
| PubChem CID | 66786181 |
| Molecular Formula | C37H46N6O4 |
| Molecular Weight | 638.81 g/mol |
| Exact Mass | 638.36 |
| IUPAC Name | [4-[3-[1-(3-methoxypropyl)benzimidazol-2-yl]piperidin-1-yl]-4-oxo-1-[4-(4-phenylpiperazin-1-yl)phenyl]butan-2-yl]carbamic acid |
| SMILES | COCCCn1c(C2CCCN(C(=O)CC(Cc3ccc(N4CCN(c5ccccc5)CC4)cc3)NC(=O)O)C2)nc2ccccc21 |
| InChI | InChI=1S/C37H46N6O4/c1-47-24-8-19-43-34-13-6-5-12-33(34)39-36(43)29-9-7-18-42(27-29)35(44)26-30(38-37(45)46)25-28-14-16-32(17-15-28)41-22-20-40(21-23-41)31-10-3-2-4-11-31/h2-6,10-17,29-30,38H,7-9,18-27H2,1H3,(H,45,46) |
| InChIKey | SFSCEQMEKBLKHO-UHFFFAOYSA-N |
| XLogP | 5.37 |
| TPSA | 103.17 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 12 |
| Heavy Atoms | 47 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
| MW ≤ 500 | 638.81 |
| LogP ≤ 5 | 5.37 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'anil_di_alk_E(186)', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'} |
|---|
Analyze [4-[3-[1-(3-methoxypropyl)benzimidazol-2-yl]piperidin-1-yl]-4-oxo-1-[4-(4-phenylpiperazin-1-yl)phenyl]butan-2-yl]carbamic acid with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of [4-[3-[1-(3-methoxypropyl)benzimidazol-2-yl]piperidin-1-yl]-4-oxo-1-[4-(4-phenylpiperazin-1-yl)phenyl]butan-2-yl]carbamic acid?
The IUPAC name of [4-[3-[1-(3-methoxypropyl)benzimidazol-2-yl]piperidin-1-yl]-4-oxo-1-[4-(4-phenylpiperazin-1-yl)phenyl]butan-2-yl]carbamic acid (CID 66786181) is [4-[3-[1-(3-methoxypropyl)benzimidazol-2-yl]piperidin-1-yl]-4-oxo-1-[4-(4-phenylpiperazin-1-yl)phenyl]butan-2-yl]carbamic acid.
What is the SMILES notation for [4-[3-[1-(3-methoxypropyl)benzimidazol-2-yl]piperidin-1-yl]-4-oxo-1-[4-(4-phenylpiperazin-1-yl)phenyl]butan-2-yl]carbamic acid?
The canonical SMILES for [4-[3-[1-(3-methoxypropyl)benzimidazol-2-yl]piperidin-1-yl]-4-oxo-1-[4-(4-phenylpiperazin-1-yl)phenyl]butan-2-yl]carbamic acid is COCCCn1c(C2CCCN(C(=O)CC(Cc3ccc(N4CCN(c5ccccc5)CC4)cc3)NC(=O)O)C2)nc2ccccc21.
What is the InChIKey of [4-[3-[1-(3-methoxypropyl)benzimidazol-2-yl]piperidin-1-yl]-4-oxo-1-[4-(4-phenylpiperazin-1-yl)phenyl]butan-2-yl]carbamic acid?
The InChIKey is SFSCEQMEKBLKHO-UHFFFAOYSA-N. The full InChI is InChI=1S/C37H46N6O4/c1-47-24-8-19-43-34-13-6-5-12-33(34)39-36(43)29-9-7-18-42(27-29)35(44)26-30(38-37(45)46)25-28-14-16-32(17-15-28)41-22-20-40(21-23-41)31-10-3-2-4-11-31/h2-6,10-17,29-30,38H,7-9,18-27H2,1H3,(H,45,46).
What are the key properties of [4-[3-[1-(3-methoxypropyl)benzimidazol-2-yl]piperidin-1-yl]-4-oxo-1-[4-(4-phenylpiperazin-1-yl)phenyl]butan-2-yl]carbamic acid?
[4-[3-[1-(3-methoxypropyl)benzimidazol-2-yl]piperidin-1-yl]-4-oxo-1-[4-(4-phenylpiperazin-1-yl)phenyl]butan-2-yl]carbamic acid has a molecular weight of 638.81 g/mol, XLogP of 5.37, 12 rotatable bonds, 2 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for [4-[3-[1-(3-methoxypropyl)benzimidazol-2-yl]piperidin-1-yl]-4-oxo-1-[4-(4-phenylpiperazin-1-yl)phenyl]butan-2-yl]carbamic acid is sourced from PubChem (CID 66786181), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).